Treatment of children with diffuse intrinsic brain stem glioma with radiotherapy, vincristine and oral VP-16: a Children's Oncology Group phase II study.
about
Brainstem Glioma in AdultsDIPG in Children - What Can We Learn from the Past?Radiotherapy with concurrent and adjuvant temozolomide in children with newly diagnosed diffuse intrinsic pontine glioma.Herpes simplex virus oncolytic therapy for pediatric malignanciesAntigen-specific immune responses and clinical outcome after vaccination with glioma-associated antigen peptides and polyinosinic-polycytidylic acid stabilized by lysine and carboxymethylcellulose in children with newly diagnosed malignant brainstemPhase II trial of tipifarnib and radiation in children with newly diagnosed diffuse intrinsic pontine gliomas.Bevacizumab as therapy for radiation necrosis in four children with pontine gliomas.Management of diffuse pontine gliomas in children: recent developments.Phase 2 study of safety and efficacy of nimotuzumab in pediatric patients with progressive diffuse intrinsic pontine glioma.Brainstem glioma: a review.A phase II study of gefitinib and irradiation in children with newly diagnosed brainstem gliomas: a report from the Pediatric Brain Tumor Consortium.Temozolomide in the treatment of children with newly diagnosed diffuse intrinsic pontine gliomas: a report from the Children's Oncology Group.Histologically proven, low-grade brainstem gliomas in children: 30-year experience with long-term follow-up at Mayo Clinic.Effect of time from diagnosis to start of radiotherapy on children with diffuse intrinsic pontine gliomaProton magnetic resonance spectroscopy predicts survival in children with diffuse intrinsic pontine glioma.Diffuse intrinsic pontine tumors: a study of primitive neuroectodermal tumors versus the more common diffuse intrinsic pontine gliomasMotexafin-gadolinium and involved field radiation therapy for intrinsic pontine glioma of childhood: a children's oncology group phase 2 study.Diffuse intrinsic pontine glioma: poised for progress.Pediatric Brain Tumors: Current Knowledge and Therapeutic OpportunitiesDiffuse intrinsic pontine glioma treated with prolonged temozolomide and radiotherapy--results of a United Kingdom phase II trial (CNS 2007 04).Protein profiling of formalin fixed paraffin embedded tissue: Identification of potential biomarkers for pediatric brainstem glioma.Nimotuzumab in pediatric glioma.Re-Examining the Need for Tissue Diagnosis in Pediatric Diffuse Intrinsic Pontine Gliomas: A Review.Genomic Insights into Diffuse Intrinsic Pontine Glioma.Diffuse intrinsic pontine glioma-current status and future strategies.Pharmacotherapeutic management of pediatric gliomas : current and upcoming strategies.Diffuse intrinsic pontine glioma: a reassessment.Survival with concurrent temozolomide and radiotherapy in pediatric brainstem glioma with relation to the tumor volume.Diffuse Intrinsic Pontine Glioma: Time for Cautious Optimism.Radiation therapy and concurrent topotecan followed by maintenance triple anti-angiogenic therapy with thalidomide, etoposide, and celecoxib for pediatric diffuse intrinsic pontine glioma.Etoposide encapsulation in surface-modified poly(lactide-co-glycolide) nanoparticles strongly enhances glioma antitumor efficiency.The potential of theragnostic ¹²⁴I-8H9 convection-enhanced delivery in diffuse intrinsic pontine gliomaRole of adaptive radiation therapy for pediatric patients with diffuse pontine glioma.Hypofractionated Radiotherapy for Children With Diffuse Intrinsic Pontine Gliomas.Expression of epidermal growth factor variant III (EGFRvIII) in pediatric diffuse intrinsic pontine gliomas.Proceedings of the diffuse intrinsic pontine glioma (DIPG) Toronto Think Tank: advancing basic and translational research and cooperation in DIPG.Voices of children and adolescents on phase 1 or phase 2 cancer trials: A new trial endpoint?A pediatric brain tumor consortium phase II trial of capecitabine rapidly disintegrating tablets with concomitant radiation therapy in children with newly diagnosed diffuse intrinsic pontine gliomas.High dose methotrexate for pediatric high grade glioma: results of the HIT-GBM-D pilot study.Clinical outcomes and natural history of pediatric brainstem tumors: with 33 cases follow-ups.
P2860
Q26739232-8EDF366F-1F11-46E1-9143-68E93C99A3D4Q26777843-09746927-73D2-4832-B575-16E393F2FCA1Q33396801-43206AE2-71E5-4BD7-8CFF-1D5E7A969885Q33713824-F1A8CC1F-2986-417B-8FCF-EADCD36A7A46Q33796170-A2C54528-7B37-4A45-8A2B-41ED9CF5D6F5Q33825938-F8DE43C0-2CC0-43F4-B65F-B89372E50BF9Q34139432-04D480CF-B426-4F18-B086-6A9BA027CA58Q34347540-7808EC37-569D-43E9-A70A-CEA7A56AAF34Q34359662-4A0E593B-5995-4F38-B6D8-8A7CD814DA2DQ34628180-CF13357C-11FC-4E4F-BB30-99AAFBF01573Q34722457-8E35E82C-10E1-4620-9147-94C939B8BB2EQ34722864-F5B44634-5235-49F4-8393-47315E8A1146Q35183137-69E858E4-2487-4BE0-80C7-4F9DAC84F123Q35230772-1A779CCB-39F4-4CC8-85AE-A31970009628Q35421487-FD9CBDD5-0228-4748-A8E5-CE331B4561EDQ36403117-B11D18D1-E55E-47B8-872A-23B9EFE0A095Q36485991-574A4E07-D656-4B76-9CE8-547670B7BD01Q36492719-C31E01A8-EF14-4C4E-8E3D-4E662AAA8C57Q37213305-ED5A6FA2-9092-4D82-96D4-862F6B961A1BQ37369556-3CD3B611-61AD-407D-97B5-C955A88DFBC6Q37533281-D9A25DE9-D180-45B2-B53C-9F3B6D88C8D5Q37630569-67E42A3B-6ACB-44EF-96A9-3F65C0BD9133Q37668034-B665C7D6-7FCE-4F10-AABB-710B3D5413D3Q37723508-26E24E97-74F5-4B08-9C87-C3D4103BD8BDQ37870759-7F2D8F7F-1782-48D8-8B70-4491C6F3CA9CQ38074880-ACAE40A2-83CB-491D-9BC1-23CDA2297B7AQ38208998-CE982454-846A-48B5-B1F5-67864E912BAFQ38672647-5BBF2FC6-0A72-41C7-9A9F-AD3F22DDB726Q38963434-A579D12D-F702-4E18-85DC-17F13CB53856Q39217689-3F56B624-2B00-48A2-85BA-813170120967Q39259254-A42BC422-BA9C-49D7-92D7-34264E311721Q39645468-C364E70A-D885-4D4E-9D5F-AB5243767863Q39668719-B9E06C5F-FFDD-49B3-BCFB-6534F576BE65Q41143911-D1B75FCB-EDE1-4675-93CB-1D34DF61C423Q41811462-9F248B03-07F1-44B8-9144-758AD78ABD48Q45384951-3AECEED9-168E-4927-9B68-CD9D93709562Q47559320-E97F2D42-7C2E-4CAA-973D-B2286619410FQ47992039-DFD1B11E-90C1-46C1-ADEB-AFF5A26E8612Q48095838-064F80C9-40E5-4E15-9348-1EE4E16EA193Q48303024-5D2089D3-BF27-4F64-9070-705BFBDBD34C
P2860
Treatment of children with diffuse intrinsic brain stem glioma with radiotherapy, vincristine and oral VP-16: a Children's Oncology Group phase II study.
description
2008 nî lūn-bûn
@nan
2008年の論文
@ja
2008年学术文章
@wuu
2008年学术文章
@zh
2008年学术文章
@zh-cn
2008年学术文章
@zh-hans
2008年学术文章
@zh-my
2008年学术文章
@zh-sg
2008年學術文章
@yue
2008年學術文章
@zh-hant
name
Treatment of children with dif ...... Oncology Group phase II study.
@en
Treatment of children with dif ...... Oncology Group phase II study.
@nl
type
label
Treatment of children with dif ...... Oncology Group phase II study.
@en
Treatment of children with dif ...... Oncology Group phase II study.
@nl
prefLabel
Treatment of children with dif ...... Oncology Group phase II study.
@en
Treatment of children with dif ...... Oncology Group phase II study.
@nl
P2093
P356
P1476
Treatment of children with dif ...... Oncology Group phase II study.
@en
P2093
Carolyn Freeman
Cynthia Kretschmar
David N Korones
James Kepner
Paul G Fisher
Tianni Zhou
Zhengjia Chen
P304
P356
10.1002/PBC.21154
P577
2008-02-01T00:00:00Z